Many life sciences companies which protect their inventions, brands or product designs through patents, trademarks or registered designs in their home country, do no...

The priority that will unite all life sciences companies in 2016 is the pursuit of greater agility. As long as organisations keep taking a short-term view, investing...

It has, since 2012, been a well-established fact that pharmaceutical companies which have medicinal products or are conducting clinical trials in the European Union ...